GeoPolitics Pulse

The Heartbeat of World events

European Commission Approves Expanded Use of HIV-1 Therapy EDURANT® (rilpivirine …

by ·

Approval provides a new treatment option for some of the youngest people living with HIV-1 in the European Union.Read More

Related posts:

  1. Perspectives of people with HIV on implementing long acting cabotegravir plus rilpivirine in …
  2. European Commission approves expanded age indication for GSK’s Arexvy, the first …
  3. European Commission grants conditional marketing authorization to Pfizer’s gene therapy …
  4. European Parliament approves new European Commission team led by Ursula von … – KUNA
  5. Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy …